Articles will include:

• Osteoporosis and bone modulation therapies: indications and outcomes
• Antiresorptive therapies for the treatment of malignant osteolytic bone disease
• Clinical presentation and staging of antiresorptive agent-induced osteonecrosis of the jaw
• Epidemiology and risk factors of antiresorptive agent-induced osteonecrosis of the jaw
• Basic science research of antiresorptive agent-induced osteonecrosis of the jaw: an update
• Pathophysiology of antiresorptive agent-induced osteonecrosis of the jaw: what we know and what we don't know
• The genetics of osteonecrosis of the jaw
• Preventive strategies for patients at risk of antiresorptive agent-induced osteonecrosis of the jaw
• Non-operative and operative therapies for treatment of antiresorptive agent-induced osteonecrosis of the jaw
• The role of anti-angiogenic therapy in the development of osteonecrosis of the jaw
• Antiresorptive therapies: what they are and how do they work, and more!